Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis - Top-Institutions - MDSpire

Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis

  • By

  • Reza Sari Motlagh

  • Mohammad Abufaraj

  • Pierre I. Karakiewicz

  • Pawel Rajwa

  • Keiichiro Mori

  • Dong-Ho Mun

  • Shahrokh F. Shariat

  • September 3, 2021

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Infectious Disease
    • Urology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Urology
    • Molecular Biology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Infectious Disease
    • Endocrinology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Molecular Medicine
    • Infectious Disease

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology
    • Urology
    • Infectious Disease

Original Source(s)

Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis

  • by Reza Sari Motlagh, Mohammad Abufaraj, Pierre I. Karakiewicz, Pawel Rajwa, Keiichiro Mori, Dong-Ho Mun, Shahrokh F. Shariat

  • September 3, 2021

Related Content

Temporal changes in the risk of six-month post-COVID symptoms: a national population-based cohort study

The impact of the COVID-19 pandemic on renal cancer care

COVID-19 webinar: COVID-19 and the rapid transition to a virtual practice

John D. Halamka, M.D., M.S., president of the Mayo Clinic Platform, and other Mayo Clinic experts discuss advanced telemedicine and the role this alternative care setting will play amid an evolving health care landscape. (Credit is available.)

  • September 3, 2020

  • 1 min